The rising incidence of eosinophilic esophagitis is associated with increasing biopsy rates, finds the latest issue of Alimentary Pharmacology & Therapeutics.
Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia, reports the latest issue of the Alimentary Pharmacology & Therapeutics.
High serum levels of free cortisol indicate severity of cirrhosis in hemodynamically stable patients, reports this month's issue of the Journal of Gastroenterology & Hepatology.
A study in November's issue of the European Journal of Gastroenterology & Hepatology evaluates 4 time-saving methods of reading capsule endoscopy videos.
The latest issue of the Alimentary Pharmacology & Therapeutics examines adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test.
A study in November's issue of the European Journal of Gastroenterology & Hepatology reports on an inappropriate use of the fecal occult blood test outside of the National Health Service colorectal cancer screening program.
A study in this week's issue of the Journal of the American Medical Association reports on a strategy to identify Lynch syndrome among patients with colorectal cancer.
November's issue of the Alimentary Pharmacology & Therapeutics reviews the effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery.
A study in the latest issue of the European Journal of Gastroenterology investigates the low incidence of reinfection with the hepatitis C virus following treatment in active drug users.
The most recent issue of the Alimentary Pharmacology & Therapeutics examined whether rifaximin treatment for irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms.
This month's issue of the European Journal of Gastroenterology & Hepatology reports on the inappropriate use of the fecal occult blood test in a university hospital.
The most recent publication by the Alimentary Pharmacology & Therapeutics evaluates the impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis.
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .